Moderna says the Food and Drug Administration has issued full approval for its COVID-19 vaccine for use in people aged 18 and older.
Moderna says the vaccine will be marketed under the brand name"Spikevax."
"This is a momentous milestone in Moderna's history as it is our first product to achieve licensure in the U.S.," Stéphane Bancel, Moderna's CEO, said in a statement."The full licensure of Spikevax in the U.S. now joins that in Canada, Japan, the European Union, the UK, Israel, and other countries, where the adolescent indication is also approved. We are grateful to the U.S. FDA for their thorough review of our application.
The Moderna vaccine was previously available for people under emergency use authorization. The Centers for Disease Control and Prevention has not yet authorized emergency use authorization for the Moderna vaccine for anyone younger than 18. The Moderna vaccine is the second COVID-19 vaccine to receive full FDA approval. The agency previously issued full approval to the Pfizer vaccine last August. .Page-below > .RichTextModule {display:none;} .Page-below .Link {font-size: 12px; padding: 5px 10px;border: 1px solid #005687;border-radius: 4px;font-family:"proxima-nova", sans-serif; } Report a typo
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Moderna COVID-19 vaccine gets full FDA approvalThe Moderna Covid-19 vaccine received full approval from the U.S. Food and Drug administration Monday, 11 months after the shot was given an emergency use authorization.
Weiterlesen »
Moderna's COVID-19 vaccine gets full FDA approvalModerna's COVID-19 vaccine called “Spikevax” has been given full approval from the U.S. Food and Drug Administration.
Weiterlesen »
Moderna COVID vaccine gets full FDA approvalThe shot has been given to tens of millions of Americans since its emergency authorization over a year ago.
Weiterlesen »
Could there be a universal vaccine for any type of coronavirus, not just COVID-19?A pan-coronavirus vaccine will be designed using features of the virus's genetic code that are shared universally across all different versions of the virus.
Weiterlesen »
What to know about BA.2, the newest COVID-19 omicron variantIt’s called the “stealth” variant, but there’s nothing particularly stealthy about it. Researchers are working to parse whether it is a new threat.
Weiterlesen »